ENXTPA:SANPharmaceuticals
Sanofi (ENXTPA:SAN) Could Be 3% Overvalued On Canada Expansion And Portfolio Shift
Sanofi (ENXTPA:SAN) just cut the ribbon on the Charles Best Building in Canada, a flu vaccine facility tied to a C$925 million biomanufacturing investment that includes substantial federal and provincial backing.
Sanofi has been busy on multiple fronts, pairing the Charles Best Building opening with a planned partnership that will transfer 20 mature medicines and three manufacturing sites to Cheplapharm in exchange for a sizeable equity stake.
Against that backdrop, the shares closed at...